Epistaxis clinical trials at UCSF

1 research study open to eligible people

Epistaxis refers to bleeding from the nose. At UCSF, there is a registry study for individuals with Hereditary Hemorrhagic Telangiectasia (HHT) to observe their health experiences. This study collects data to better understand how HHT influences nosebleeds and other medical conditions.

Showing trials for

  • Comprehensive HHT Outcomes Registry of the United States (CHORUS)

    open to all eligible people

    The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is an observational registry of patients diagnosed with Hereditary Hemorrhagic Telangiectasia (HHT). The purpose of this study is to better understand HHT, the symptoms and…

    San Francisco, California and other locations

Last updated: